Table 1.
Baseline Demographic and Clinical Characteristics and BAY 81‐8973 Treatment Assignment for Chinese and Non‐Chinese Patients in LEOPOLD II
| Chinese (n = 23) | Non‐Chinese (n = 57) | |
|---|---|---|
| Median (range) age, y | 27.0 (15‐48) | 30.0 (14‐59) |
| Race, n (%) | ||
| Asian | 23 (100) | 9 (15.8) |
| White | n/a | 36 (63.2) |
| Black | n/a | 4 (7.0) |
| Hispanic | n/a | 8 (14.0) |
| Target joint present, n (%) | 23 (100) | 49 (86.0) |
| Median (range) number of target joints | 2.0 (1‒7) | 3.0 (0‒9)a |
| Median (range) number of bleeds in past 12 mo | 60.0 (14‒106) | 33.0 (3‒106)b |
| Median (range) number of joint bleeds in past 12 mo | 43.0 (1‒90) | 23.5 (3‒104)b |
| Median (range) age at diagnosis, y | 2.3 (0‒26) | 1.3 (0‒22) |
| Median (range) age at first treatment, y | 2.9 (0‒18) | 1.6 (0‒22) |
| BAY 81‐8973 treatment, n (%) | ||
| Combined prophylaxis | 17 (73.9) | 42 (73.7) |
| 2×/wk prophylaxis | 7 (30.4) | 21 (36.8) |
| 3×/wk prophylaxis | 10 (43.5) | 21 (36.8) |
| On‐demand | 6 (26.0) | 15 (26.3) |
a
Data available for 56 patients.
b
Data available for 54 patients.